XML 47 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 8 - Segment Information
 6 Months Ended
Sep. 30, 2014
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]

Note 8 - Segment Information


We have three reporting segments: Biological Indicators, Instruments and Continuous Monitoring. The following tables set forth our segment information (in thousands):


   

Three Months Ended September 30, 2014

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 6,441     $ 9,065     $ 3,034     $ 18,540  
                                 

Gross profit

  $ 4,051     $ 5,455     $ 1,617     $ 11,123  

Selling expenses

    368       829       145       1,342  
    $ 3,683     $ 4,626     $ 1,472       9,781  

Reconciling items (1)

                            (5,038 )

Earnings before income taxes

                          $ 4,743  
                                 

   

Three Months Ended September 30, 2013

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 6,010     $ 6,666     $ --     $ 12,676  
                                 

Gross profit

  $ 3,482     $ 4,118     $ --     $ 7,600  

Selling expenses

    556       863       --       1,419  
    $ 2,926     $ 3,255     $ --       6,181  

Reconciling items (1)

                            (3,243 )

Earnings before income taxes

                          $ 2,938  

   

Six Months Ended September 30, 2014

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 12,858     $ 16,750     $ 5,332     $ 34,940  
                                 

Gross profit

  $ 7,835     $ 10,382     $ 2,611     $ 20,828  

Selling expenses

    772       1,821       812       3,405  
    $ 7,063     $ 8,561     $ 1,799       17,423  

Reconciling items (1)

                            (9,787 )

Earnings before income taxes

                          $ 7,636  

   

Six Months Ended September 30, 2013

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 10,864     $ 13,030     $ --     $ 23,894  
                                 

Gross profit

  $ 6,043     $ 8,354     $ --     $ 14,397  

Selling expenses

    946       1,556       --       2,502  
    $ 5,097     $ 6,798     $ --       11,895  

Reconciling items (1)

                            (5,942 )

Earnings before income taxes

                          $ 5,953  

(1) Reconciling items include general and administrative, research and development, and other expenses.


   

September 30, 2014

   

March 31, 2014

 

Total assets

               

Biological Indicators

  $ 26,582     $ 22,771  

Instruments

    46,023       36,797  

Continuous Monitoring

    31,182       28,578  

Corporate and administrative

    8,313       9,383  
    $ 112,100     $ 97,529  

All long-lived assets are located in the United States except for $3,161,000 which are associated with our subsidiary which is located in Chassieu, France.


Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):


   

Three Months Ended

September 30,

   

Six Months Ended

September 30,

 
   

2014

   

2013

   

2014

   

2013

 

Net revenues from unaffiliated customers:

                               

United States

  $ 9,698     $ 7,794     $ 18,189     $ 13,824  

Foreign

    8,842       4,882       16,751       10,070  
    $ 18,540     $ 12,676     $ 34,940     $ 23,894  

No foreign country exceeds 10% of total revenues.